In a way their Pharmacy strategy could be a hedge of sorts against a softening private health market. Interesting footnote that plays a big part in their future plans that is constantly downplayed in reports.
Ann: Presentation FY2019 Results Briefing, page-7
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RHC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$42.36 |
Change
-0.420(0.98%) |
Mkt cap ! $9.753B | |||
| Open | High | Low | Value | Volume |
| $42.77 | $42.90 | $42.36 | $30.23M | 689.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 72 | $42.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $42.55 | 450 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| RHC (ASX) Chart |